Medical Properties Trust (NYSE:MPT – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.02), Zacks reports. The business had revenue of $250.14 million for the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The firm’s revenue was up 5.3% compared to the same quarter last year.
Here are the key takeaways from Medical Properties Trust’s conference call:
- Annualized cash rental revenue has surpassed $1 billion despite approximately $600 million of property sales, and management expects cash rents to remain above that level in 2027.
- MPT completed a $2.4 billion secured-debt refinancing, capturing approximately $123 million in net discounts, and expects its next financing steps to eliminate maturities until June 2028 while increasing covenant and secured-financing flexibility.
- HSA’s hospitals reportedly showed improving operations, with overall volume up 14%, surgeries up 33%, and cash collections up 24% since August; however, MPT has not projected when rent payments will resume because billing and collection problems remain unresolved.
- MPT agreed to reduce Priory’s annual rent by approximately 18% amid U.K. NHS budget constraints, although the agreement includes potential rent recovery as revenue improves, stronger parent-company credit support, and a potential lease extension through 2055.
- Management highlighted strong performance across several major operators, including MEDIAN, Circle Health, Swiss Medical Network, IMED, Ernest Health, and NOR; NOR is expected to resume paying 100% of contractual rent in December.
Medical Properties Trust Price Performance
Shares of NYSE MPT traded down $0.31 during mid-day trading on Thursday, reaching $2.44. The company’s stock had a trading volume of 35,722,169 shares, compared to its average volume of 7,730,057. The stock has a 50-day moving average of $3.49 and a two-hundred day moving average of $4.38. The stock has a market capitalization of $1.46 billion, a P/E ratio of -40.67 and a beta of 1.45. The company has a debt-to-equity ratio of 2.16, a quick ratio of 3.12 and a current ratio of 3.12. Medical Properties Trust has a 1-year low of $2.35 and a 1-year high of $6.47.
Medical Properties Trust Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 8th. Stockholders of record on Thursday, September 10th were issued a dividend of $0.09 per share. The ex-dividend date of this dividend was Thursday, September 10th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 14.8%. Medical Properties Trust’s dividend payout ratio is presently -600.00%.
Wall Street Analyst Weigh In
MPT has been the subject of a number of recent research reports. Weiss Ratings lowered Medical Properties Trust from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 18th. Wells Fargo & Company decreased their price target on Medical Properties Trust from $5.00 to $3.80 and set an “underweight” rating for the company in a report on Tuesday, September 1st. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Sell” and a consensus target price of $4.15.
View Our Latest Report on Medical Properties Trust
Trending Headlines about Medical Properties Trust
Here are the key news stories impacting Medical Properties Trust this week:
- Positive Sentiment: Progress on asset sales provided a partial offset to the earnings disappointment, potentially improving liquidity and helping MPT reduce debt. Medical Properties trades higher despite Q3 earnings miss amid progress in asset sales
- Neutral Sentiment: Third-quarter revenue rose 5.3% year over year to approximately $250.1 million, indicating top-line growth despite ongoing challenges. However, MPT reported a negative net margin and negative return on equity. MPT Reports Third Quarter Results
- Negative Sentiment: Normalized funds from operations came in at $0.11 per share, below the $0.13 analyst consensus and down from $0.13 in the year-earlier quarter. The shortfall raises concerns about the sustainability of MPT’s cash-generating capacity. Medical Properties Q3 FFO and Revenues Miss Estimates
- Negative Sentiment: Tenant troubles were severe enough to “preclude payment of September rent,” intensifying investor concerns about occupancy, rent collections and future cash flow. Medical Properties Trust Sinks 13% as FFO Misses and Tenant Troubles Precluded Payment of September Rent
- Negative Sentiment: The combination of the FFO miss, tenant payment issues and the company’s continuing losses outweighed the revenue growth and asset-sale progress, driving the stock lower and increasing pressure on management to strengthen the balance sheet.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a healthcare-focused real estate investment trust (REIT) that owns and invests in healthcare facilities. Its portfolio has historically included hospitals, inpatient rehabilitation facilities, long-term acute-care hospitals, behavioral health facilities and other properties used by healthcare providers.
Founded in 2003 and headquartered in Birmingham, Alabama, the company primarily generates income by leasing properties to healthcare operators under long-term agreements.
See Also
- Five stocks we like better than Medical Properties Trust
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.
